M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT

Synthesis of pyrrolidine-based analogues of 2-acetamidosugars as N-acetyl glucosaminidase inhibitors
occuring acetamido-containing pyrolidine was isolated so far: Pochonicine. [4] [5] [6] The main classes of synthetic nitrogen functionalized polyhydroxylated pyrrolidines are represented in Figure 1 , the most studied one being the 2,5-dideoxy-2,5-iminohexitols A [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] but other scaffolds such as B, [22] [23] [24] C, [25] [26] D, 27 E 28 and F 8 have also been prepared. It is rather stricking that structure G, which can be seen as a combination of A and E possessing as many hydroxyl groups as the hexosaminidase substrate and product, has never been synthesized and assessed as a hexosaminidase inhibitor. The present study reports the synthesis and hexosaminidase inhibitory evaluation of molecules derived from scaffold G. In the course of our studies aimed at the synthesis of GlcNAc-like piperidine homoiminosugars exploiting a ring-contraction methodology, 29-32 a 2,3-trans-2-hydroxy,3-azido-azepane was required and obtained from the unsaturated 7-membered ring 1. 33 The obvious synthetic route transits via the formation of an epoxide, followed by its azidolysis. We observed that it was possible to operate the epoxydation with some degree of stereocontrol to afford either epoxides 2 or 3 as the main products. 33 These latter could then be opened using sodium azide to
give, in both cases, a significant amount of the 2-azido derivatives 4 and 6 together with the desired 3-azido compounds 5 and 7. Compounds 4 and 6 33 are also suitable candidates for a ring contraction reaction 34 to give pyrrolidine derivatives 35 through a γ-aminoacohol rearrangement. Hence, we decided to apply the TFAA-mediated ring contraction conditions developped by Cossy 36 to β-azidoazepanes 4 and 6 that were first converted into the N-benzyl derivatives 8 (80%) and 13 (68%) respectively, using TFA followed by Nbenzylation (BnBr, K 2 CO 3 ). Their ring contraction with TFAA furnished the azidopyrrolidines 9 (93%) and 14 (86%) respectively in good yield. Reduction of the azide moiety (PPh 3 , THF/H 2 O) followed by N-acetylation was achieved to provide the acetamide 10 (80%) and 15 (60%) respectively. Final O-deacetylation followed by hydrogenolysis yielded the target pyrrolidines 11 (95%) and 16 (88%). Compound 9 was also directly submitted to the action of hydrogen in the presence of Pd/C to give the diamine 12 in 95% yield as its hydrochloride salt (Scheme 2). In conclusion, a ring-contraction methodology applied to seven-membered iminosugars bearing an azido group in β position furnished a low micromolar hexosaminidase inhibitor after conversion of the azide function into an acetamide and final deprotection. This work complements previous work on the conversion of polyhydroxylated azepanes into six-membered NHAc-homoiminosugars.
Experimental
Material and methods
All commercial reagents were used as supplied. Solvents (DMF, THF) were distilled under anhydrous conditions. TLC plates (Macherey-Nagel, ALUGRAM NMR experiments were recorded with a Bruker AM-400 spectrometer at 400
MHz for 1 H nuclei and at 100 MHz for 13 were recorded on a Bruker microTOF spectrometer, using Tuning-Mix as reference. Optical rotations were measured on a Perkin-Elmer 341 digital polarimeter or a Jasco P-2000 polarimeter with a path length of 1 dm.
tert-butyl (2R,3R,4R,5R,6S)-6-azido-3,4-bis(benzyloxy)-2-((benzyloxy)methyl)-5-hydroxyazepane-1-carboxylate (4)
Known epoxide 2 33 
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(3S,4R,5R,6R,7R)-3-azido-1-benzyl-5,6-bis(benzyloxy)-7-((benzyloxy)methyl)azepan-4-ol (8)
To 
(R)-2-acetamido-2-((2R,3R,4R,5R)-1-benzyl-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)pyrrolidin-2-yl)ethyl acetate (10)
To a solution of azide 9 (28 mg, 0.044 mmol) in THF/H 2 O (2.0 mL/1.0mL) was 1-((2R,3R,4R,5R) 
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N-((R)-
N-((R)-1-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl)-2-hydroxyethyl)amonium (12)
9 (10 mg, 0.017 mmol) was dissolved in MeOH (2 mL) and aqueous HCl (1M, 0.2 mL) was added under argon. After adding Pd/C (10%, 10 mg), the argon was removed. The H 2 was introduced and the mixture was bubbled for 5 minutes. After stirring the solution for 24 under H 2 atmosphere, the mixture was filtered on microfilter 0.3 µm). The solvent was evaporated to give the desired product (4.5 mg, 95%). 
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tert-butyl (2R,3R,4R,5S,6R)-6-azido-3,4-bis(benzyloxy)-2-((benzyloxy)methyl)-5-hydroxyazepane-1-carboxylate (6)
To a solution of known epoxide 3 33 (160 mg, 0.294 mmol) in a mixture of DMF/H 2 O (2.9/0.3 mL) was added NaN 3 (88 mg, 1. 
(3R,4S,5R,6R,7R)-3-azido-1-benzyl-5,6-bis(benzyloxy)-7-((benzyloxy)methyl)azepan-4-ol (13)
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To a solution of 6 (42 mg, 0.071 mmol) in CH 2 Cl 2 (4 mL) was added trifluoroacetic acid (2 mL) and the obtained solution was stirred at room temperature for 1h. The solution was evaporated and co-evaporated with toluene (3x5 mL). -A new family of amino-functionalised pyrolidines was synthesized.
(S)-2-azido-2-((2R
,
(S)-2-acetamido-2-((2S
N-((S)-1-((2S
-Aring-contraction of β-azido,γ-hydroxyazepanes was used.
-A low micromolar inhibitor of β-N-acetylehexosaminidase identified.
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